Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats

International Dairy Journal

Volumn 22, Issue 1, 2012, Pages 24-30

  Uenishi, Hiroshi ^a   Kabuki, Toshihide ^a   Seto, Yasuyuki ^a   Serizawa, Atsushi ^a   Nakajima, Hadjime ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE FRACTION; BLOOD GLUCOSE; CROSS-OVER; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; INHIBITORY ACTIVITY; INHIBITORY PEPTIDES; ISOLATION AND IDENTIFICATION; LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; PLASMA GLUCOSE; RAT MODEL; RIPENING PERIODS; TYPE-2 DIABETES;

CASEIN; GLUCOSE; LIQUID CHROMATOGRAPHY; LIQUIDS; PEPTIDES; RATS;

SOLVENT EXTRACTION;

RATTUS;

EID: 82655173852     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2011.08.002     Document Type: Article

References (45)

1. Abubakar A., Saito T., Kitazawa H., Kawai Y., Itoh T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. Journal of Dairy Science 1998, 81:3131-3138.
2. Ahrén B., Gomis R., Standl E., Mills D., Schweizer A. Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care 2004, 27:2874-2880.
3. Ahrén B., Landin-Olsson M., Jansson P.A., Svensson M., Holmes D., Schweizer A. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2004, 89:2078-2084.
4. Ahrén B., Simonsson E., Larsson H., Landin-Olsson M., Torgeirsson H., Jansson P.A., et al. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care 2002, 25:869-875.
5. Anders H.F., Mikael N., Jens J.H., Bjorck I.M.E. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. American Journal of Clinical Nutrition 2005, 82:69-75.
6. Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi F. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. American Journal of Clinical Nutrition 2005, 82:523-530.
7. Balkan B., Kwasnik L., Miserendino R., Holst J.J., Li X. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 1999, 42:1324-1331.
8. Chiba H., Tani F., Yoshikawa M. Opioid antagonist peptides derived from kappa-casein. Journal of Dairy Research 1989, 56:363-366.
9. Cummings N.K., James A.P., Soares M.J. The acute effects of different sources of dietary calcium on postprandial energy metabolism. British Journal of Nutrition 2006, 96:138-144.
10. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regulatory Peptides 2005, 128:117-124.
11. Demuth H.U., McIntosh C.H., Pederson R.A. Type 2 diabetes-therapy with dipeptidyl peptidase IV inhibitors. Biochimica et Biophysica Acta 2005, 1751:33-44.
12. Deutsch S.M., Molle D., Gagnaire V., Piot M., Atlan D., Lortal S. Hydrolysis of sequenced β-casein peptides provides new insight into peptidase activity from thermophilic lactic acid bacteria and highlights intrinsic resistance of phosphopeptides. Applied and Environmental Microbiology 2000, 66:5360-5367.
13. FitzGerald R.J. Potential uses of caseinophosphopeptides. International Dairy Journal 1998, 8:451-457.
14. Gomez-Ruiz J.A., Ramos M., Recio I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. International Dairy Journal 2002, 12:697-706.
15. Higurashi S., Kunieda Y., Matsuyama H., Kawakami H. Effect of cheese consumption on the accumulation of abdominal adipose and decrease in serum adiponectin levels in rats fed a calorie dense diet. International Dairy Journal 2007, 17:1224-1231.
16. IDF. (1982) Cheese and processed cheese - Detremination of the total solids content. ISO 5534(1985)-IDF standard 4A. Brussels, Belgium: International Dairy Federation.
17. IDF Cheese and processed cheese products - Determination of chloride content - Potentiometric titration method 2006, ISO 5943-IDF 088, International Dairy Federation, Brussels, Belgium.
18. IDF Milk - Determination of fat content - Gerber butyrometer 2008, ISO 488-IDF 105, International Dairy Federation, Brussels, Belgium.
19. Jacobsen R., Lorenzen J.K., Toubro S., Krog-Mikkelsen I., Astrup A. Effect of short-term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. International Journal of Obesity 2005, 29:292-301.
20. Kim W., Egan J.M. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacological Reviews 2008, 60:470-512.
21. Kuchroo C.N., Fox P.F. Soluble nitrogen in Cheddar cheese: comparison of extraction procedures. Milchwissenschaft 1982, 37:331-335.
22. Kunji E.R., Mierau I., Hagting A., Poolman B., Konings W.N. The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek 1996, 70:187-221.
23. Liljeberg E.H., Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulinaemia. European Journal of Clinical Nutrition 2001, 55:994-999.
24. McIntosh C.H.S., Demuth H.-U., Kim S.-J., Pospisilik J.A., Pederson R.A. Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus. International Journal of Biochemistry and Cell Biology 2006, 38:860-872.
25. Mozaffarian D., Cao H., King I.B., Lemaitre R.N., Song X., Siscovick D.S., et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Annals of Internal Medicine 2010, 153:790-799.
26. Ness A.R., Smith G.D., Hart C. Milk, coronary heart disease and mortality. Journal of Epidemiology and Community Health 2001, 55:379-382.
27. Ohsawa K., Satsu H., Ohki K., Enjoh M., Takano T., Shimizu M. Producibility and digestibility of antihypertensive β-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. Journal of Agricultural and Food Chemistry 2008, 56:854-858.
28. Ostman E.L.M., Liljeberg Elmstahl H.G.M., Bjorck I.M.E. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. American Journal of Clinical Nutrition 2001, 74:96-100.
29. Pappenheimer J.R., Dahl C.E., Karnovsky M.L., Maggio J.E. Intestinal absorption and excretion of octapeptides composed of D amino acids. Proceedings of the National Academy of Sciences of the United States of America. 1994, 91:1942-1945.
30. Pederson R.A., White H.A., Schlenzig D., Pauly R.P., McIntosh C.H., Demuth H.U. Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 1998, 47:1253-1258.
31. Pereira M.A., Jacobs D.R., Van Horn L., Slattery M.L., Kartashov A.I., Ludwig D.S. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. Journal of the American Medical Association 2002, 287:2081-2089.
32. Pospisilik J.A., Stafford S.G., Demuth H.U., Brownsey R., Parkhouse W., Finegood D.T., et al. Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia and β-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 2002, 51:943-950.
33. Reimer M.K., Holst J.J., Ahre'n B. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. European Journal of Endocrinology 2002, 146:717-727.
34. Rizzello C.G., Losito I., Gobbetti M., Carbonara T., De Bari M.D., Zambonin P.G. Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties. Journal of Dairy Science 2005, 88:2348-2360.
35. Schneeman B.O., Burton-Freeman B., Davis P. Incorporating dairy foods into low and high fat diets increases the postprandial cholecystokinin response in men and women. Journal of Nutrition 2003, 133:4124-4128.
36. Shimizu M., Tsunogai M., Arai S. Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 1997, 18:681-687.
37. Sieber R., Bütikofer U., Egger C., Portmann R., Walther B., Wechsler D. ACE-inhibitory activity and ACE-inhibiting peptides in different cheese varieties. Dairy Science and Technology 2010, 90:47-73.
38. Sudre B., Broqua P., White R.B., Ashworth D., Evans D.M., Haigh R., et al. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male Zucker diabetic fatty rats. Diabetes 2002, 51:1461-1469.
39. Sugiyama M., Tang A.C., Wakaki Y., Koyama W. Glycemic index of single and mixed meal foods among common Japanese foods with white rice as a reference food. European Journal of Clinical Nutrition 2003, 57:743-752.
40. Upadhyay V.K., McSweeney P.L.H., Magboul A.A.A., Fox P.F. Proteolysis in cheese during ripening. Cheese: Chemistry, physics and microbiology 2004, vol. 1:391-433. Elsevier Academic Press, London, UK. 3rd ed. P.F. Fox, P.L.H. McSweeney, T.M. Cogan, T.P. Guinee (Eds.).
41. Van den Berg G., Meijer W.C., Düsterhoft E.-M., Smit G. Gouda and related cheeses. Cheese: Chemistry, physics and microbiology 2004, vol. 2:103-140. Elsevier Academic Press, London, UK. 3rd ed. P.F. Fox, P.L.H. McSweeney, T.M. Cogan, T.P. Guinee (Eds.).
42. Van der Pijl P.C., Kies A.K., Ten Have A.M., Duchateau G.S.M.J.E., Deutz N.E.P. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 2008, 29:2196-2202.
43. Warensjo E., Nolan D., Tapsell L. Dairy food consumption and obesity-related chronic disease. Advances in Food and Nutrition Research 2010, 59C:1-41.
44. Yasuda N., Inoue T., Nagakura T., Yamazaki K., Kira K., Saeki T., et al. Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats. Journal of Pharmacology and Experimental Therapeutics 2004, 310:614-619.
45. Zemel M.B. Role of calcium and dairy products in energy partitioning and weight management. American Journal of Clinical Nutrition 2004, 79:907S-912S.